Efficacy of Inspiratory Muscle Training on Elite Swimmers (PEAK)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03062735 |
|
Recruitment Status : Unknown
Verified November 2016 by Universidade do Porto.
Recruitment status was: Recruiting
First Posted : February 23, 2017
Last Update Posted : February 23, 2017
|
Sponsor:
Universidade do Porto
Information provided by (Responsible Party):
Universidade do Porto
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Brief Summary:
This study is a randomized controlled trial on the efficacy of inspiratory muscle training on swimming performance, airway dysfunction and perceived breathlessness in elite swimmers.
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Reactive Airways Dysfunction Syndrome (Disorder) Muscle Weakness Dyspnea | Other: Inspiratory Muscle Training Other: Sham Inspiratory Muscle Training | Not Applicable |
Only a few studies have assessed the impact of Inspiratory Muscle Training (IMT) on swim performance with unclear and inconsistent results. This study aims to evaluate the effect of a 12-week IMT program in swimming performance, airway dysfunction and perceived breathlessness among elite swimmers. Participants will be recruited from the elite competitive Futebol Clube do Porto swimming team. After consent, individuals will be randomly allocated into the IMT or Sham-IMT group. A pressure threshold device will be used to perform the inspiratory training. The IMT group will perform 30 inspiratory efforts, 5 times a week, twice a day, against a pressure threshold load equivalent to 50% of maximal inspiratory pressure (MIP). Sham-IMT group will follow a similar protocol, except for the inspiratory effort that will be made against 15% of MIP. Measures of lung function, swimming performance, airway dysfunction, inspiratory muscle strength and perceived breathlessness will be assessed at the beginning and then in 4 weeks intervals until the end of study period. All outcome measures will be assessed by an investigator who will be not involved in the intervention process. Data will be expressed as mean ± standard deviation (SD) and respective 95% confidence interval. The significance level will be 5% (p˂0.05).
| Study Type : | Interventional (Clinical Trial) |
| Estimated Enrollment : | 40 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | Double (Participant, Investigator) |
| Primary Purpose: | Other |
| Official Title: | Protocol for a Randomized Controlled Trial Evaluating the Efficacy of Inspiratory Muscle Training on Swimming Performance, Airway Dysfunction and Perceived Breathlessness in Elite Swimmers |
| Actual Study Start Date : | February 6, 2017 |
| Estimated Primary Completion Date : | April 2017 |
| Estimated Study Completion Date : | May 2017 |
Resource links provided by the National Library of Medicine
MedlinePlus related topics:
Breathing Problems
| Arm | Intervention/treatment |
|---|---|
|
Experimental: Inspiratory Muscle Training
Inspiratory Muscle Training intervention (Sham-IMT) groups during a 3 months training season. A pressure threshold device (POWERbreathe - HaB International Ltd., UK) will be used to IMT. The IMT group will perform 30 inspiratory efforts, 5 times a week, twice daily, for 12 weeks, against a pressure threshold load equivalent to 50% of maximal inspiratory pressure (MIP).
|
Other: Inspiratory Muscle Training
The Inspiratory Muscle Training (IMT) group will perform 30 inspiratory efforts, 5 times a week, twice a day, for 12 weeks, against a pressure threshold load equivalent to 50% of maximal inspiratory pressure. |
|
Sham Comparator: Sham Inspiratory Muscle Training
Sham-IMT group will follow a similar protocol, except the inspiratory effort that will be made against 15% MIP. The duration of each IMT session will be 30 inspirations. After the initial setting of training loads, the IMT group will be instructed to periodically increase load so that only 30 maneuvers could be completed. The Sham-IMT group will not receive these instructions. All the IMT sessions, in both groups will take place before swimming training and will be supervised throughout the intervention period to ensure that technique and load will be appropriate.
|
Other: Sham Inspiratory Muscle Training
The Sham Inspiratory Muscle Training (Sham-IMT) group will perform 30 inspiratory efforts, 5 times a week, twice a day, for 12 weeks, against a pressure threshold load equivalent to 15% of maximal inspiratory pressure. |
Primary Outcome Measures :
- Swimming time trials performance [ Time Frame: twelve weeks ]Changes in time-trial swim performance
Information from the National Library of Medicine
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 14 Years to 40 Years (Child, Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
Criteria
Inclusion Criteria:
- Healthy elite swimmers engaged in competitive training for a minimum period of three years;
- Individuals with no disability;
- Individuals aged between 14 and 40 years.
Exclusion Criteria:
- Individuals presenting co-morbidities or physical impairment that affects regular training;
- Smokers;
- Athletes already in a regular respiratory muscle training program
- Individuals with a predicted forced expiratory volume in the first second (FEV1) below 60%.
Information from the National Library of Medicine
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03062735
Contacts
| Contact: Marisa Cunha, MSc | 00351914955278 | anamarisa_c@hotmail.com |
Locations
| Portugal | |
| Faculty of Medicine of Porto University | Recruiting |
| Porto, Portugal, 4200-319 | |
| Contact: André Moreira, MD, PhD 00351932730090 andremoreira@med.up.pt | |
Sponsors and Collaborators
Universidade do Porto
Investigators
| Principal Investigator: | André Moreira, MD, PhD | Faculty of Medicine of the University of Porto |
| Responsible Party: | Universidade do Porto |
| ClinicalTrials.gov Identifier: | NCT03062735 |
| Other Study ID Numbers: |
PEAKNORTE-01-0145-FEDER-000010 |
| First Posted: | February 23, 2017 Key Record Dates |
| Last Update Posted: | February 23, 2017 |
| Last Verified: | November 2016 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
Additional relevant MeSH terms:
|
Muscle Weakness Dyspnea Respiration Disorders Respiratory Tract Diseases Signs and Symptoms, Respiratory Pathologic Processes |
Muscular Diseases Musculoskeletal Diseases Neuromuscular Manifestations Neurologic Manifestations Nervous System Diseases |